Interaction of organic cations with a newly identified plasma membrane monoamine transporter

Molecular Pharmacology

Volumn 68, Issue 5, 2005, Pages 1397-1407

  Engel, Karen ^a   Wang, Joanne ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CATION; CIMETIDINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 4; GUANIDINE; HISTAMINE; ORGANIC CATION TRANSPORTER; PLASMA MEMBRANE MONOAMINE TRANSPORTER; PROTEIN INHIBITOR; QUINIDINE; QUININE; RHODAMINE 123; TETRYLAMMONIUM; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CATION TRANSPORT; CELL STRAIN; CHEMICAL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYDROPHOBICITY; MASS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; STIMULATION;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; DOGS; HUMANS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; ORGANIC CATION TRANSPORT PROTEINS; TYRAMINE;

EID: 27544453846     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.016832     Document Type: Article

References (36)

1. Acimovic Y and Coe IR (2002) Molecular evolution of the equilibrative nucleoside transporter family: identification of novel family members in prokaryotes and eukaryotes. Mol Biol Evol 19:2199-2210.
2. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, and Young JD (2004) The equilibrative nucleoside transporter family, SLC29. Pflueg Arch Eur J Physiol 447:735-743.
3. Baldwin SA, Yao SY, Hyde RJ, Ng AM, Foppolo S, Barnes K, Ritzel MW, Cass CE, and Young JD (2005) Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem 280:15880-15887.
4. Bednarczyk D, Ekins S, Wikel JH, and Wright SH (2003) Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1. Mol Pharmacol 63:489-498.
5. Breidert T, Spitzenberger F, Grundemann D, and Schomig E (1998) Catecholamine transport by the organic cation transporter type 1 (OCT1). Br J Pharmacol 125:218-224.
6. Busch AE, Karbach U, Miska D, Gorboulev V, Akhoundova A, Volk C, Arndt P, Ulzheimer JC, Sonders MS, Baumann C, et al. (1998) Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine and memantine. Mol Pharmacol 54:342-352.
7. Busch AE, Quester S, Ulzheimer JC, Gorboulev V, Akhoundova A, Waldegger S, Lang F, and Koepsell H (1996) Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1. FEBS Lett 395:153-156.
8. Chen R and Nelson JA (2000) Role of organic cation transporters in the renal secretion of nucleosides. Biochem Pharmacol 60:215-219.
9. Dresser MJ, Gray AT, and Giacomini KM (2000) Kinetic and selectivity differences between rodent, rabbit and human organic cation transporters (OCT1). J Pharmacol Exp Ther 292:1146-1152.
10. Dresser MJ, Leabman MK, and Giacomini KM (2001) Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. J Pharmacol Sci 90:397-421.
11. Eisenhofer G (2001) The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 91:35-62.
12. Engel K, Zhou M, and Wang J (2004) Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 279:50042-50049.
13. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE, and Koepsell H (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16:871-881.
14. Grundemann D, Liebich G, Kiefer N, Koster S, and Schomig E (1999) Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 56:1-10.
15. Grundemann D, Schechinger B, Rappold GA, and Schomig E (1998) Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1:349-351.
16. Hayer-Zillgen M, Bruss M, and Bonisch H (2002) Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol 136:829-836.
17. Iversen LL (1965) The uptake of adrenaline by the rat isolated heart. Br J Pharmacol 24:387-394.
18. Jonker JW and Schinkel AH (2004) Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2 and 3 (SLC22A1-3). J Pharmacol Exp Ther 308:2-9.
19. Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ, Leibach FH, and Ganapathy V (1998) Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 273:15971-15979.
20. Koepsell H and Endou H (2003) The SLC22 drug transporter family. Pflueg Arch Eur J Physiol 447:666-676.
21. Koepsell H, Schmitt BM, and Gorboulev V (2003) Organic cation transporters. Rev Physiol Biochem Pharmacol 150:36-90.
22. Kong W, Engel K, and Wang J (2004) Mammalian nucleoside transporters. Curr Drug Metab 5:63-84.
23. Martel F, Keating E, and Azevedo I (2001) Effect of P-glycoprotein modulators on the human extraneuronal monoamine transporter. Eur J Pharmacol 422:31-37.
24. Nagel G, Volk C, Friedrich T, Ulzheimer JC, Bamberg E, and Koepsell H (1997) A reevaluation of substrate specificity of the rat cation transporter rOCT1. J Biol Chem 272:31953-31956.
25. Suhre WM, Ekins S, Chang C, Swaan PW, and Wright SH (2005) Molecular deter-minants of substrate/inhibitor binding to the human and rabbit renal organic cation transporters hOCT2 and rbOCT2. Mol Pharmacol 67:1067-1077.
26. Sweet DH, Miller DS, and Pritchard JB (2001) Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus. J Biol Chem 276:41611-41619.
27. Sweet DH and Pritchard JB. (1999) rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchanger. Am J Physiol 277:F890-F898.
28. Takeda M, Khamdang S, Narikawa S, Kimura H, Kobayashi Y, Yamamoto T, Cha SH, Sekine T, and Endou H (2002) Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther 300:918-924.
29. Urakami Y, Okuda M, Masuda S, Saito H, and Inui KI (1998) Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. J Pharmacol Exp Ther 287:800-805.
30. +-dependent purine nucleoside transporter from human kidney: cloning and functional characterization. Am J Physiol 273:F1058-F1065.
31. Wright SH and Dantzler WH (2004) Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84:987-1049.
32. Wu X, Huang W, Ganapathy ME, Wang H, Kekuda R, Conway SJ, Leibach FH, and Ganapathy V (2000) Structure, function and regional distribution of the organic cation transporter OCT3 in the kidney. Am J Physiol 279:F449-F458.
33. Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, and Ganapathy V (1998) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273:32776-32786.
34. Zhang L, Dresser MJ, Gray AT, Yost SC, Terashita S, and Giacomini KM (1997) Cloning and functional expression of a human liver organic cation transporter. Mol Pharmacol 51:913-921.
35. Zhang L, Gorset W, Dresser MJ, and Giacomini KM (1999) The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1. J Pharmacol Exp Ther 288:1192-1198.
36. Zhang L, Schaner ME, and Giacomini KM (1998) Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). J Pharmacol Exp Ther 286:354-361.